CLASS ACTION UPDATE for APA, CYDY and KDMN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / April 5, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
APA Shareholders Click Here: https://www.zlk.com/pslra-1/apache-corporation-loss-submission-form?prid=14377&wire=1
CYDY Shareholders Click Here: https://www.zlk.com/pslra-1/cytodyn-inc-loss-submission-form?prid=14377&wire=1
KDMN Shareholders Click Here: https://www.zlk.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=14377&wire=1
* ADDITIONAL INFORMATION BELOW *
Apache Corporation (NASDAQ:APA)
APA Lawsuit on behalf of: investors who purchased September 7, 2016 - March 13, 2020
Lead Plaintiff Deadline: April 26, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/apache-corporation-loss-submission-form?prid=14377&wire=1
According to the filed complaint, during the class period, Apache Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) Apache intentionally used unrealistic assumptions regarding the amount and composition of available oil and gas in Alpine High; (ii) Apache did not have the proper infrastructure in place to safely and/or economically drill and/or transport those resources even if they existed in the amounts purported; (iii) these misleading statements and omissions artificially inflated the value of the Company's operations in the Permian Basin; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
CytoDyn Inc. (OTCMKT:CYDY)
CYDY Lawsuit on behalf of: investors who purchased March 27, 2020 - March 9, 2021
Lead Plaintiff Deadline: May 17, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cytodyn-inc-loss-submission-form?prid=14377&wire=1
According to the filed complaint, during the class period, CytoDyn Inc. made materially false and/or misleading statements and/or failed to disclose that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.
Kadmon Holdings, Inc. (NASDAQ:KDMN)
KDMN Lawsuit on behalf of: investors who purchased October 1, 2020 - March 10, 2021
Lead Plaintiff Deadline: June 2, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=14377&wire=1
According to the filed complaint, during the class period, Kadmon Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com:
https://www.accesswire.com/639016/CLASS-ACTION-UPDATE-for-APA-CYDY-and-KDMN-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders
